Contact
![Contact Meredith Alda](https://cdn.statcdn.com/contactPerson/3646.jpg)
Mon - Fri, 9am - 6pm (EST)
![Contact Yolanda Mega](https://cdn.statcdn.com/contactPerson/3195.jpg)
Mon - Fri, 9am - 5pm (SGT)
![Contact Kisara Mizuno](https://cdn.statcdn.com/contactPerson/2661.jpg)
Mon - Fri, 10:00am - 6:00pm (JST)
![Contact Lodovica Biagi](https://cdn.statcdn.com/contactPerson/863.jpg)
Mon - Fri, 9:30am - 5pm (GMT)
![Contact Carolina Dulin](https://cdn.statcdn.com/contactPerson/3012.jpg)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in Lebanon has been experiencing significant growth in recent years.
Customer preferences: Lebanon has a high demand for pharmaceuticals due to an aging population and a high prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Customers in Lebanon prefer branded drugs over generic drugs, despite the higher cost. This is due to the perception that branded drugs are of higher quality and more effective.
Trends in the market: The Pharmaceuticals market in Lebanon has been growing steadily due to an increase in the number of pharmacies and the expansion of private health insurance coverage. The market is dominated by multinational pharmaceutical companies, which have a strong presence in the country. There has also been an increase in the number of local pharmaceutical companies, which are focused on producing generic drugs.
Local special circumstances: The political and economic situation in Lebanon has had a significant impact on the Pharmaceuticals market. The country has been facing a severe economic crisis, which has led to a shortage of foreign currency. This has made it difficult for pharmaceutical companies to import raw materials and finished products, leading to a shortage of certain drugs. The COVID-19 pandemic has also had an impact on the market, with an increase in demand for certain drugs and medical supplies.
Underlying macroeconomic factors: The economic crisis in Lebanon has led to a devaluation of the local currency, making imported drugs more expensive. This has led to an increase in the cost of healthcare for consumers, who are already struggling with the high cost of living. The political instability in the country has also led to a lack of investment in the healthcare sector, with many hospitals and clinics facing financial difficulties. The COVID-19 pandemic has highlighted the weaknesses in the healthcare system, with a shortage of hospital beds, medical equipment, and healthcare workers. In conclusion, the Pharmaceuticals market in Lebanon is facing significant challenges due to the economic crisis and political instability in the country. However, the high demand for pharmaceuticals and the expansion of private health insurance coverage are driving growth in the market. The trend towards branded drugs and the preference for multinational pharmaceutical companies is likely to continue, despite the higher cost. The local pharmaceutical industry is also expected to grow, as companies focus on producing generic drugs to meet local demand.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)